Deciphering the plasma membrane hallmarks of apoptotic cells: Phosphatidylserine transverse redistribution and calcium entry

BMC Cell Biology

Volumn 2, Issue , 2001, Pages

  Martínez, M Carmen ^a,b   Freyssinet, Jean Marie ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; CALCIUM IONOPHORE; CASPASE; CYTOCHROME P450; DNA FRAGMENT; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CALCIUM TRANSPORT; CELL FUNCTION; CELL MEMBRANE; CELL MUTANT; CELL STIMULATION; CONTROLLED STUDY; ELECTRIC CAPACITANCE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MEMBRANE POTENTIAL; MEMBRANE TRANSPORT; MITOCHONDRIAL MEMBRANE; PHENOTYPE; PHOSPHOLIPID TRANSFER; PLASTICITY; PROTEIN LOCALIZATION; SCOTT SYNDROME;

EID: 2342611072     PISSN: 14712121     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2121-2-20     Document Type: Article

References (54)

1. Nicotera P, Orrenius S: The role of calcium in apoptosis. Cell Calcium 1998, 23:173-180
2. Putney JW, Ribeiro CM: Signaling pathways between the plasma membrane and endoplasmic reticulum calcium stores. Cell Mol Life Sci 2000, 57:1272-1286
3. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992, 148:2207-2216
4. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR: Early distribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initialing stimulus: inhibition by overxpression of Bcl-2 and Abl. J Exp Med 1995, 182:1545-1556
5. Martin SJ, Finucane DM, Amarante-Mendes GP, O'Brien GA, Green DR: Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem 1996, 271:28753-28756
6. Hampton MB, Vanags DM, Pörn-Ares MI, Orrenius S: Involvement of extracellular calcium in phosphatidylserine exposure during apoptosis. FEBS Lett 1996, 399:277-282
7. Bratton DL, Fadok VA, Richter DA, Kailey JM, Guthrie LA, Henson PM: Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J Biol Chem 1997, 272:26159-26165
8. Verhoven B, Schlegel RA, Williamson P: Mechanism of phosphatidylserine exposure, a phagocyte recognition signal on apoptotic T lymphocytes. J Exp Med 1995, 182:1597-1601
9. Schlegel RA, Callahan M, Krahling S, Pradhan D, Williamson P: Mechanisms for recognition and phagocytosis of apoptotic lymphocytes by macrophages. Adv Exp Med Biol 1996, 406:21-28
10. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM: A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000, 405:85-90
11. Weiss HJ: Scott syndrome: a disorder of platelet coagulant activity. Semin Hematol 1994, 31:312-319
12. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM: Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996, 87:1409-1415
13. Zwaal RFA, Schroit AJ: Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997, 89:1121-1132
14. Kojima H, Newton-Nash D, Weiss HJ, Zhao J, Sims PJ, Wiedmer T: Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest 1994, 94:2237-2244
15. Williamson P, Christie A, Kohlin T, Schlegel RA, Comfurius P, Harmsma M, Zwaal RFA, Bevers EM: Phospholipid scramblase activation pathways in lymphocytes. Biochemistry 2001, 40:8065-8072
16. Putney JW Jr: intimate plasma membrane-ER interactions underlie capacitative calcium entry. Cell 1999, 99:5-8
17. Le Deist F, Hivroz C, Partiseti M, Thomas C, Buc HA, Oleastro M, Belohradsky B, Choquet D, Fischer A: A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. Blood 1995, 85:1053-1062
18. Gardner JP, Balasubramanyam M, Studzinski GP: Up-regulation of Ca2+ influx mediated by store-operated channels in HL60 cells induced to differentiate by 1 alpha,25-dihydroxyvitamin D3. J Cell Physiol 1997, 172:284-295
19. Jayadev S, Petranka JG, Cheran SK, Biermann JA, Barrett JC, Murphy E: Reduced capacitative calcium entry correlates with vesicle accumulation and apoptosis. J Biol Chem 1999, 274:8261-8268
20. Williams SS, French JN, Gilbert M, Rangaswami AA, Knox SJ: Bcl-2 overexpression results in enhanced capacitative calcium entry and resistance to SKF-96365-induced apoptosis. Cancer Res 2000, 60:4358-4361
21. Partiseti M, Le Deist F, Hivroz C, Fischer A, Korn H, Choquet D: The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J Biol Chem 1994, 269:32327-32335
22. Martinez MC, Martin S, Toti F, Fressinaud E, Dachary-Prigent J, Meyer D, Freyssinet JM: Significance of capacitative Ca2+ entry in the regulation of phosphatidylserine expression at the surface of stimulated cells. Biochemistry 1999, 38:10092-10098
23. Kunzelmann-Marche C, Freyssinet JM, Martínez MC: Regulation of phosphatidylserine transbilayer redistribution by store-operated Ca2+ entry: Role of actin cytoskeleton. J Biol Chem 2001, 276:5134-5139
24. Pasquet JM, Dachary-Prigent J, Nurden AT: Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem 1996, 239:647-654
25. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, Leigh BK, McCarthy SA, Moores KE, Rink TJ: SK&F 9 a novel inhibitor of receptor-mediated calcium entry. Biochem J 6365, 271:515-522
26. Sargeant P, Clarkson WD, Sage SO, Heemskerk JW: Calcium influx evoke bu Ca2+ store depletion in human platelets is more susceptible to cytchrome P-450 inhibitors than receptor-mediated calcium entry. Cell Calcium 1992, 13:533-564
27. BG Hoebel, Kostner GM, Graier WF: Activation of microsomal cytochrome P450 mono-oxygenase by Ca2+ store depletion and its contribution to Ca2+ entry in porcine aortic endothelial cells. Br J Pharmacol 1997, 121:1579-1588
28. Rzigalinski BA, Willoughby KA, Hoffman SW, Falck JR, Ellis EF: Calcium influx factor, further evidence it is 5,6-epoxyeicosatrienoic acid. J Biol Chem 1999, 274:175-182
29. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995, 376:37-43
30. Lemaire C, Andreau K, Souvannavong V, Adam A: Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Lett 1998, 425:266-270
31. Castedo M, Hirsch T, Susin SA, Zamzami N, Marchetti P, Macho A, Kroemer G: Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol 1996, 157:512-521
32. Gidon-Jeangirard C, Hugel B, Holl V, Toti F, Laplanche JL, Meyer D, Freyssinet JM: Annexin V delays apoptosis while exerting an external constraint preventing the release of CD4+ and PrPc+ membrane particles in a human T lymphocyte model. J Immunol 1999, 162:5712-5718
33. Lepple-Wienhues A, Belka C, Laun T, Jekle A, Walter B, Wieland U, Welz M, Heil L, Kun J, Busch G, Weller M, Bamberg M, Gulbins E, Lang F: Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids. Proc Natl Acad Sci USA 1999, 96:13795-13800
34. Bian X, Hughes FMJ, Huang Y, Cidlowski JA, Putney JW Jr: Roles of cytoplasmic Ca2+ and intracellular Ca2+ stores in induction and suppression of apoptosis in S49 cells. Am J Physiol 1997, 272:C1241-C1249
35. Wertz IE, Dixit VM: Characterization of calcium release-activated apoptosis in LNCaP prostate cancer cells. J Biol Chem 2000, 275:11470-11477
36. Preston GA, Barrett JC, Biermann JA, Murphy E: Effects of alterations in calcium homeostasis on apoptosis during neoplastic progression. Cancer Res 1997, 57:537-542
37. Li W, Tait JF: Regulatory effect of CD9 on calcium-stimulated phosphatidylserine exposure in Jurkat T lymphocytes. Arch Bioch Bioph 1998, 351:89-95
38. Fadeel B, Gleiss B, Hogstrand K, Chandra J, Wiedmer T, Sims PJ, Henter JI, Orrenius S, Samali A: Phosphatidylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression. Biochem Biophys Res Commun 1999, 266:504-511
39. Frasch SC, Henson PM, Kailey JM, Richter DA, Janes MS, Fadok VA, Bratton DL: Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cδ . J Biol Chem 2000, 275:23065-23073
40. Sims PJ, Wiedmer T: Unraveling the mysteries of phospholipid scrambling. Thromb Haemost 2001, 86:266-275
41. Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D, Chimini G: ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2000, 2:399-406
42. Stout JG, Basse F, Luhm RA, Weiss HJ, Wiedmer T, Sims PJ: Scott syndrome erythrocytes contain a membrane protein capable of mediating Ca2+-dependent transbilayer migration of membrane phospholipids. J Clin Invest 1997, 99:2232-2238
43. Zhou Q, Sims PJ, Wiedmer T: Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome. Blood 1998, 92:1707-1712
44. Janel N, Leroy C, Laude I, Toti F, Fressinaud E, Meyer D, Freyssinet JM, Kerbiriou-Nabias D: Assessment of the expression of candidate human plasma membrane phospholipid scramblase in Scott syndrome cells. Thromb Haemost 1999, 81:322-323
45. van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P, van Meer G: MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 1996, 87:507-517
46. Zhuang J, Ren Y, Snowden RT, Zhu H, Gogvadze V, Savill JS, Cohen GM: Dissociation of phagocyte recognition of cells undergoing undergoing apoptosis from other features of the apoptotic program. J Biol Chem 1998, 273:15628-15632.
47. Hirt UA, Gantner F, Leist M: Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms. J Immunol 2000, 164:6520-6529
48. Diaz C, Lee AT, McConkey DJ, Schroit AJ: Phosphatidylserine externalization during differentiation-triggered apoptosis of erythroleukemic cells. Cell Death Differ 1999, 6:218-226
49. Brown SB, Clarke MCH, Magowan L, Sanderson H, Savill J: Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. J Biol Chem 2000, 275:5987-5996
50. Berard M, Mondière P, Casamayor-Pallejà M, Hennino A, Bella C, Defrance T: Mitochondria connects the antigen receptor to effector caspases during B cell receptor-induced apoptosis in normal human B cells. J Immunol 1999, 163:4655-4662
51. Bouchon A, Krammer PH, Walczak H: Critical role for mitochondria in B cell receptor-mediated apoptosis. Eur J Immunol 2000, 30:69-77
52. Aupeix K, Hugel B, Martin T, Bischoff P, Lill H, Pasquali JL, Freyssinet JM: The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 1997, 99:1546-1554
53. Mancini M, Anderson BO, Caldwell E, Sedghinasab M, Paty PB, Hockenbery DM: Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J Cell Biol 1997, 138:449-469
54. Connor J, Bucana C, Fidler IJ, Schroit AJ: Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: Quantitative assessment of outer-leaflet lipid in prothrombinase complex formation. Proc Natl Acad Sci USA 1989, 86:3184-3188